Navigation Links
Tasker Products Installs Scalder Application at New Poultry Processor's Facility
Date:2/11/2008

FAIR LAWN, N.J., Feb. 11 /PRNewswire-FirstCall/ -- Tasker Products Corp. (OTC Bulletin Board: TKER), a manufacturer and marketer of proprietary technology effective in inhibiting pathogenic bacteria, today reported that it has installed its equipment to dispense its poultry processing application, Tasker Blue, in a new plant operated by one of the top 10 poultry processors. The plant will conduct a short test of the application to gauge its effectiveness, during which it will purchase the product at a trial price. Following this trial period, future orders of the Tasker Blue would be at regular market prices.

Greg Osborn, Tasker's executive chairman, said, "The Food Safety Inspection Service ('FSIS') of the United States Department of Agriculture ('USDA') recently published new policies for Salmonella Verification sampling. Under the new policy, beginning on March 28, establishments operating at poor Salmonella performance levels of category 2 or category 3 will be posted in the FSIS website. The program, Salmonella Initiative Program ('SIP'), is voluntary; however, processors wishing to continue using on-line reprocessing or operate under HIMP (HACCP-based Inspection Models Project), must participate in the program. Under SIP, processors will be required to test for Salmonella, E Coli and Campylobacter during the rehang and post-chill points. If a processor cannot achieve category 1 (the best level), then they must intensify the frequency of testing. As an incentive, the FSIS is also providing five SIP establishments that have achieved category 1 and have delivered superior results with further waivers, such as the authorization to increase line speeds."

Mr. Osborn continued, "The SIP program heightens the needs for processors to ensure that bacteria are arrested early during the processing cycle in order to meet the tightening regulations. Tasker Blue is a leading product in the control of bacteria in the scalder, picker, and NY Dress cabinet; all pre-evisceration intervention points. Furthermore, the FSIS has already released an outline for additional rules proposed for 2009, which include additional testing points and further tightening of the standards. These initiatives introduced into poultry processing by the FSIS are also reaching the turkey and meat processing industry. We expect these developments to accelerate the market penetration of Tasker's poultry processing applications and our launch into beef."

Lanny Dacus, Tasker's president and CEO, added, "We recently showcased Tasker Blue at the International Poultry Expo in Atlanta, Georgia. The response to our product was exciting. Increased regulatory pressure to more effectively address Salmonella bacteria at multiple intervention points, including the scalder, has heightened interest in Tasker Blue. We are now scheduling many installations at poultry processors who are interested in running trials to confirm the product's efficacy and its positive effect on yield production. We are confident this will lead to continued roll-outs of our scalder application and achieving our goals."

About Tasker Products

Tasker is a manufacturer, distributor and marketer of eco-chemistry products with various applications that use the pHarlo technology. The pHarlo technology utilizes a highly charged and acidified, yet stable and safe, solution that enables copper sulfate, a compound with bacteriostatic properties, to remain active throughout a wide range of pH values. The Company currently markets Unifresh(R) Footbath, a grooming aid product for dairy cows, Tasker Blue(R), an antibacterial solution for use in processing poultry and Pacific Blue(TM) Seafood Spray, an antibacterial spray for retail seafood counters. Tasker Products Corp. is headquartered in Fair Lawn, New Jersey. To be added to the news distribution list or to present any questions, send an email to tasker@grannusfinancial.com. Additional information about Tasker is also available at http://www.taskerproducts.com.

This release contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statement. Actual future results and trends may differ materially from those made in or suggested by any forward-looking statements due to a variety of factors, including, for example, our ability to obtain new financing and/or generate revenue growth in the near future; our history of losses; our limited experience in the marketing of our products; our ability to compete with other products in our market space; and the risk of unfavorable federal regulation. Consequently, you should not place undue reliance on these forward-looking statements. We discuss these and other risks and uncertainties in greater detail in the filings we make with the Securities and Exchange Commission, including under the section entitled, "Risk Factors" in the Company's Annual Report on Form 10-K, as amended, for the year ended December 31, 2006 and our most recent report on Form 10-Q.

Investor Contact:

Grannus Financial Advisors, Inc. (212-681-4100)

or

taskerproducts@grannusfinancial.com


'/>"/>
SOURCE Tasker Products Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Tasker Products to Showcase Tasker Blue at International Poultry Expo
2. China Shenghuo to Market 12Ways(R) Skin Care Products in the U.S. through Agreement with Home Shopping Group
3. Kiwa Bio-Tech Products Group Discusses Cooperative Research With the University of Waterloo, Canada
4. GSK Extends GeneGo License and Adds New Products
5. Kiwa Bio-Tech Products Group Discusses Cooperative Efforts With Canadian Agricultural Ministry and Canadian Company
6. Statement by John Bailey, Chief Scientist: The Personal Care Products Council Response to Study on Phthalate Exposure in Baby Care Products
7. Remergent(R) Announces the Launch of Four New Products Pioneers of DNA Repair Expand Anti-Aging Line
8. Sales of Stem Cell Products Expected to Reach $87 Million in 2008, Leading Medical Industry Analyst Says
9. Kiwa Bio-Tech Products Group Holds Meetings to Build Distribution Network
10. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
11. China Biologic Products Gains Financial Support from Shandong Provincial Government on the Improvement of Production Facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, into ... for over 35 years, is proud to add Target to its list of ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):